Cervical Cancer Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
- Ovarian Cancer
- +2 more
- Gynaecological laparoscopic surgery (Sirius System)
- Wong Chuk Hang, Hong KongGleneagles Hospital Hong Kong
2022-04-01
Apr 1, 2022N
Recruiting
- HPV Positive Cancer
- +4 more
- PRGN-2009
- M7824
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Cervical Cancer
- +4 more
- PDS0101
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Cervical Cancer
- +4 more
- HDR Brachytherapy
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022C
Recruiting
- Cervical Cancer
- CCRT
- Paclitaxel, Cisplatin
- Chongqing, Chongqing, ChinaChongqing Cancer Hospital
2022-03-29
Mar 29, 2022G
Recruiting
- Cervical Cancer
- Metastatic Cervical Cancer
- Washington, District of Columbia
- +2 more
2022-04-05
Apr 5, 2022H
Recruiting
- Gastric Cancer
- +8 more
- Los Angeles, California
- +2 more
2022-04-05
Apr 5, 2022C
Recruiting
- Cervical Cancer
- Lymph node dissection
- +2 more
- Chongqing, Chongqing, ChinaChongqing Cancer Hospital
2022-03-29
Mar 29, 2022N
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
- Grand Rapids, Michigan
- +2 more
2022-04-05
Apr 5, 2022G
Active, not recruiting
- Cervical Cancer
- Daegu, Korea, Republic of
- +7 more
2022-04-04
Apr 4, 2022C
Recruiting
- HPV Infection
- +3 more
- Vaginal Biopsy
- Orléans, FranceCHR Orléans
2022-04-05
Apr 5, 2022R
I
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
- Anchorage, Alaska
- +34 more
2022-04-04
Apr 4, 2022S
Recruiting
- Cervical Cancer
- tisotumab vedotin
- +5 more
- Birmingham, Alabama
- +96 more
2022-04-01
Apr 1, 2022S
Recruiting
- Non-small Cell Lung Cancer
- +11 more
- Birmingham, Alabama
- +26 more
2022-04-01
Apr 1, 2022N
Not yet recruiting
- Pancreatic Cancer
- +15 more
- NGM438
- NGM438 plus pembrolizumab
- (no location specified)
2022-03-27
Mar 27, 2022P
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- NEO-201 in combination with pembrolizumab
- Bethesda, MarylandNational Cancer Institute
2022-04-01
Apr 1, 2022N
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +4 more
- Scottsdale, Arizona
- +11 more
2022-03-31
Mar 31, 2022A
Recruiting
- Clear Cell Renal Cell Cancer
- +8 more
- AZD8701
- Durvalumab
- La Jolla, California
- +22 more
2022-03-23
Mar 23, 2022O
Completed
- Cervical Cancer
- Education Program and Music Therapy
- Samsun, TurkeyYavuz Selim Family Health Center
2022-03-31
Mar 31, 2022L
Recruiting
- Cervical Cancer
- +4 more
- Beijing, Beijing, ChinaLei Li
2022-03-25
Mar 25, 2022I
Recruiting
- CIN3
- +2 more
- HPV screening
- Buenos Aires, Argentina
- +11 more
2022-04-01
Apr 1, 2022A
Recruiting
- Advanced Solid Tumor
- +9 more
- Phoenix, Arizona
- +20 more
2022-03-31
Mar 31, 2022M
Recruiting
- Solid Organ Transplant Recipient
- +6 more
- No intervention
- Copenhagen NV, Region Hovedstaden, Denmark
- +2 more
2022-03-21
Mar 21, 2022A
